Join
Live feed
·
INSIDERFilingvia Quantisnow
Atea Pharmaceuticals Inc. logo

EVP, Chief Accounting Officer Foster Wayne converted options into 41,333 shares and covered exercise/tax liability with 12,132 shares, increasing direct ownership by 58% to 79,329 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AVIR (Atea Pharmaceuticals Inc.) and more on Quantisnow.